Altimmune, inc. (ALT)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Sep'10Jun'10
Research grants and contracts

-

-

-

-

-

-

-

-

-

-

-

-

294

-

896

587

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

License revenue

-

-

-

-

-

-

-

-

-

-

-

-

4

-

4

158

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total revenue

-

-

-

-

-

-

-

-

-

-

-

-

299

-

901

745

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Revenue

2,212

575

643

1,626

2,955

2,588

2,634

2,417

2,690

-

4,591

3,037

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Contract revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,005

1,266

1,155

1,149

7,068

1,826

962

3,658

3,742

3,653

3,488

4,295

6,475

6,013

6,696

6,316

6,149

6,239

5,260

6,428

6,337

6,243

4,779

Operating expenses:
Research and development

7,187

2,873

8,729

2,945

3,217

3,064

4,728

4,918

5,746

4,459

5,905

5,254

2,786

2,409

2,400

1,381

1,029

1,171

1,125

1,222

1,613

1,791

1,728

2,372

3,427

4,097

2,556

3,402

5,233

4,746

5,138

4,918

4,705

4,531

4,884

5,984

5,820

6,172

5,940

General and administrative

2,331

2,014

2,187

2,231

2,066

2,419

1,963

2,933

2,447

1,593

3,038

1,794

2,030

1,656

3,289

966

1,193

975

1,231

1,819

2,196

2,621

3,192

2,419

2,677

4,580

4,086

2,332

2,279

2,624

3,275

2,780

2,948

2,678

3,283

3,409

4,939

3,177

4,121

Impairment charges

-

-

1,000

-

-

24,450

0

0

490

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Goodwill impairment charges

-

-

-

-

-

-

-

-

-

-

26,600

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Restructuring expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

26

422

35

2,060

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Depreciation

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

37

32

35

36

37

36

37

36

39

43

44

41

52

-

72

-

-

-

-

-

-

-

-

Depreciation

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

76

85

-

114

116

117

258

254

Total operating expenses

9,519

4,887

11,917

5,176

5,284

29,934

6,692

7,852

8,685

15,373

35,544

7,049

4,816

4,028

5,690

2,348

2,260

2,206

2,814

3,114

5,907

4,449

4,958

4,828

6,144

8,721

6,687

5,777

7,565

7,440

8,486

7,775

7,739

7,322

8,281

9,510

10,877

9,608

10,316

Loss from operations

-7,306

-4,312

-11,273

-3,550

-2,328

-27,345

-4,058

-5,435

-5,994

-12,564

-30,952

-4,011

-4,517

-3,445

-4,789

-1,602

-1,254

-940

-1,658

-1,964

1,161

-2,623

-3,996

-1,169

-2,401

-5,067

-3,199

-1,481

-1,090

-1,427

-1,790

-1,458

-1,590

-1,082

-3,021

-3,081

-4,539

-3,364

-5,537

Other income (expense):
Changes in fair value of warrant liability

-

-

-76

46

-

-

-806

5,228

-1,547

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Changes in fair value of warrant liability, including gain (loss) on exchange

-

-

-

-

-

-

-

-

-

-

-508

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Realization of cumulative translation adjustment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-1,227

-

-

-

-

-

-

-

-

Changes in fair value of embedded derivative

-

-

-

-

-

0

185

4

-7

-

-1

-

-

-

-

-

39

-277

359

-120

338

44

-560

782

242

736

-628

352

-905

249

508

823

-991

-

2,898

-

-

-

-

Interest expense

1

0

0

0

0

127

166

1

0

2

2

97

60

-

9

9

-

-

-

-

25

-

46

56

69

-

89

100

-

97

112

111

3

14

9

15

15

946

921

Interest income (expense), net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-1

-

-9

-13

-

-

-

-

-

-

-

-

-99

-

-

-

-

-

-

-

-

-

-

Realization of cumulative translation adjustment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

229

-

-

0

0

-

-

-

-

-

-

-1,227

-

-

-

-

-

-

-

-

Interest income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

1

-

-

-

-

-

-

-

-

-

-

-

Interest income

151

194

224

239

185

148

21

25

31

-

15

4

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

5

4

2

6

3

3

3

0

2

Other income - litigation

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other income, net

25

21

-23

-29

46

-11

31

-0

257

-4

10

0

-1

40

3

-6

4

1

-0

-1

9

0

0

-1

0

-2

0

2

-6

25

-31

0

52

-11

95

-32

-11

-93

29

Change in fair value of derivative instruments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

688

2,488

75

33

Total other income, net

175

215

275

163

231

6

877

-5,200

1,829

621

-485

-92

-61

-17

-5

-14

42

-282

349

-364

322

7

-607

724

173

654

-717

256

-1,010

164

1,598

717

-938

1,831

2,988

643

2,464

-963

-855

Net loss before income tax benefit

-7,131

-4,096

-10,997

-3,386

-2,097

-27,339

-3,180

-10,635

-4,165

-11,942

-31,438

-4,104

-4,578

-

-4,795

-1,617

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss before income taxes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-1,211

-1,222

-1,309

-2,329

1,483

-2,615

-4,603

-445

-2,228

-4,412

-3,917

-1,225

-2,101

-1,262

-191

-740

-2,529

749

-33

-2,437

-2,075

-

-

Income tax benefit

-3,245

-

-58

-

-

-2,831

-829

-1,497

-991

-

-1,532

-993

-

-

-

-

15

15

15

11

19

-

25

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Income tax (provision) benefit

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-6

29

-

28

11

9

-

22

16

150

-

-

-

-

-

-

Net loss

-3,885

-4,096

-10,939

-3,386

-2,097

-24,507

-2,351

-9,138

-3,173

-8,830

-29,905

-3,110

-4,578

-3,447

-4,795

-1,617

-1,226

-1,238

-1,324

-2,340

1,463

-2,629

-4,628

-439

-2,258

-4,424

-3,945

-1,236

-2,111

-1,269

-213

-756

-2,679

749

-33

-2,437

-2,075

-4,328

-6,392

Other comprehensive loss — foreign currency translation adjustment

-

-

-

-

-

0

0

-1,078

615

-

-1,028

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other comprehensive loss – unrealized loss on investments

-32

-

18

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Comprehensive loss

-3,918

-

-

-

-2,097

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other comprehensive income (loss) - foreign currency translation adjustments

-

-

-

-

-

-

-

-

-

-

-

-1,256

-579

-

1,316

2,614

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Comprehensive loss

-

-

-10,920

-3,386

-

-

-2,351

-10,217

-2,558

-6,641

-30,933

-1,853

-3,998

-

-6,111

-4,231

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss

-3,885

-4,096

-10,939

-3,386

-2,097

-24,507

-2,351

-9,138

-3,173

-8,830

-29,905

-3,110

-4,578

-

-4,795

-1,617

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deemed dividends

-

-

-

-

452

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Preferred stock accretion and other deemed dividends

-

-

-

-

-

780

-64

700

1,891

2,804

1,962

44

118

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Preferred stock accretion and dividends

-

-

-

-

-

-

-

-

-

-

-

-

-

-

104

87

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss attributed to common stockholders

-3,885

-4,096

-10,939

-3,386

-2,550

-25,288

-2,287

-9,838

-5,064

-11,635

-31,867

-3,155

-4,697

-

-4,899

-1,704

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Weighted-average common shares outstanding, basic and diluted

15,110

15,113

14,768

13,127

9,489

8,255

1,321

956

676

-17,953

517

12,245

6,917

-50,581

6,911

6,911

64,404

-

-

-

-

-

58,952

54,670

-

52,361

52,166

49,749

48,359

48,350

48,345

48,325

48,269

48,224

48,194

46,631

46,276

-

-

Net loss per share attributed to common stockholders, basic and diluted

-0.26

-0.33

-0.74

-0.26

-0.27

4.35

-1.73

-10.29

-7.49

-56.40

-61.57

-0.26

-0.68

-0.68

-0.71

-0.25

-0.02

-

-

-

-

-

-0.08

-0.01

-

-0.09

-0.08

-0.02

-0.04

-0.02

0.00

-0.02

-0.06

0.01

0.00

-0.05

-0.04

-0.14

-0.22

Net income (loss) attributable to common stockholders

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-2,258

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Basic net income (loss) per share

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.01

-0.02

-0.04

0.02

-

-

-

-0.04

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Diluted net income (loss) per share

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.01

-0.02

-0.04

0.02

-

-

-

-0.04

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Weighted-average shares used in calculation of basic net income (loss) per share

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

64,377

64,187

63,745

63,633

-

-

-

53,044

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Weighted-average shares used in calculation of diluted net income (loss) per share

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

64,030

64,187

63,745

63,979

-

-

-

53,044

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Weighted average shares used in calculation of basic and diluted net loss per share

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

31,946

29,619